Mexico's precursor chemical controls

Emergence of less potent types of methamphetamine in the United States

James K Cunningham, Jane Carlisle Maxwell, Octavio Campollo, Lon Mu Liu, William J. Lattyak, Russell C. Callaghan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: This study examines whether Mexico's controls on ephedrine and pseudoephedrine, the two precursor chemicals that yield the most potent form of methamphetamine, d-methamphetamine, impacted the prevalence/availability of less potent types of methamphetamine in the United States-types associated with the alternative precursor chemical P2P. Method: Using ARIMA-intervention time series analysis of monthly drug exhibits (a prevalence/availability indicator) from the System to Retrieve Information from Drug Evidence (STRIDE), we tested whether Mexico's controls, which began in 2005, were associated with growth/decline in d-methamphetamine and growth/decline in P2P-associated, less potent l-methamphetamine, racemic methamphetamine (a 50:50 ratio of d- and l-isomers), and mixed isomer methamphetamine (an unequal ratio of d- and l-isomers). Heroin, cocaine and marijuana exhibits were used for quasi-control (01/2000-04/2011). Results: Mixed-isomer exhibits constituted about 4% of the methamphetamine exhibits before Mexico's controls, then rose sharply in association with them and remained elevated, constituting about 37% of methamphetamine exhibits in 2010. d-Methamphetamine exhibits dropped sharply; l-methamphetamine and racemic methamphetamine exhibits had small rises. d-Methamphetamine exhibits partially recovered in the US West, but little recovery occurred in the US Central/South. Quasi-control series were generally unaffected. Conclusion: The US methamphetamine market changed. Widespread emergence of less potent methamphetamine occurred in conjunction with Mexico's controls. And prevalence/availability of the most potent type of the drug, d-methamphetamine, declined, a partial recovery in the West notwithstanding. Granting that lower potency drugs typically engender less dependence and attendant problems, these findings suggest that, following Mexico's controls, the potential harm of a sizeable amount of the US methamphetamine supply decreased.

Original languageEnglish (US)
Pages (from-to)125-136
Number of pages12
JournalDrug and Alcohol Dependence
Volume129
Issue number1-2
DOIs
StatePublished - Apr 1 2013

Fingerprint

Methamphetamine
Mexico
Isomers
Availability
Pharmaceutical Preparations
Pseudoephedrine
Recovery
Ephedrine
Time series analysis
Heroin
Cannabis
Growth

Keywords

  • 1-Phenyl-2-propanone (P2P)
  • Isomer
  • Methamphetamine
  • Mexico
  • Precursors
  • Pseudoephedrine
  • System to Retrieve Information from Drug Evidence (STRIDE)

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Mexico's precursor chemical controls : Emergence of less potent types of methamphetamine in the United States. / Cunningham, James K; Maxwell, Jane Carlisle; Campollo, Octavio; Liu, Lon Mu; Lattyak, William J.; Callaghan, Russell C.

In: Drug and Alcohol Dependence, Vol. 129, No. 1-2, 01.04.2013, p. 125-136.

Research output: Contribution to journalArticle

Cunningham, James K ; Maxwell, Jane Carlisle ; Campollo, Octavio ; Liu, Lon Mu ; Lattyak, William J. ; Callaghan, Russell C. / Mexico's precursor chemical controls : Emergence of less potent types of methamphetamine in the United States. In: Drug and Alcohol Dependence. 2013 ; Vol. 129, No. 1-2. pp. 125-136.
@article{26b543d58d1e418ebf3fc692842ae760,
title = "Mexico's precursor chemical controls: Emergence of less potent types of methamphetamine in the United States",
abstract = "Background: This study examines whether Mexico's controls on ephedrine and pseudoephedrine, the two precursor chemicals that yield the most potent form of methamphetamine, d-methamphetamine, impacted the prevalence/availability of less potent types of methamphetamine in the United States-types associated with the alternative precursor chemical P2P. Method: Using ARIMA-intervention time series analysis of monthly drug exhibits (a prevalence/availability indicator) from the System to Retrieve Information from Drug Evidence (STRIDE), we tested whether Mexico's controls, which began in 2005, were associated with growth/decline in d-methamphetamine and growth/decline in P2P-associated, less potent l-methamphetamine, racemic methamphetamine (a 50:50 ratio of d- and l-isomers), and mixed isomer methamphetamine (an unequal ratio of d- and l-isomers). Heroin, cocaine and marijuana exhibits were used for quasi-control (01/2000-04/2011). Results: Mixed-isomer exhibits constituted about 4{\%} of the methamphetamine exhibits before Mexico's controls, then rose sharply in association with them and remained elevated, constituting about 37{\%} of methamphetamine exhibits in 2010. d-Methamphetamine exhibits dropped sharply; l-methamphetamine and racemic methamphetamine exhibits had small rises. d-Methamphetamine exhibits partially recovered in the US West, but little recovery occurred in the US Central/South. Quasi-control series were generally unaffected. Conclusion: The US methamphetamine market changed. Widespread emergence of less potent methamphetamine occurred in conjunction with Mexico's controls. And prevalence/availability of the most potent type of the drug, d-methamphetamine, declined, a partial recovery in the West notwithstanding. Granting that lower potency drugs typically engender less dependence and attendant problems, these findings suggest that, following Mexico's controls, the potential harm of a sizeable amount of the US methamphetamine supply decreased.",
keywords = "1-Phenyl-2-propanone (P2P), Isomer, Methamphetamine, Mexico, Precursors, Pseudoephedrine, System to Retrieve Information from Drug Evidence (STRIDE)",
author = "Cunningham, {James K} and Maxwell, {Jane Carlisle} and Octavio Campollo and Liu, {Lon Mu} and Lattyak, {William J.} and Callaghan, {Russell C.}",
year = "2013",
month = "4",
day = "1",
doi = "10.1016/j.drugalcdep.2012.10.001",
language = "English (US)",
volume = "129",
pages = "125--136",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Mexico's precursor chemical controls

T2 - Emergence of less potent types of methamphetamine in the United States

AU - Cunningham, James K

AU - Maxwell, Jane Carlisle

AU - Campollo, Octavio

AU - Liu, Lon Mu

AU - Lattyak, William J.

AU - Callaghan, Russell C.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Background: This study examines whether Mexico's controls on ephedrine and pseudoephedrine, the two precursor chemicals that yield the most potent form of methamphetamine, d-methamphetamine, impacted the prevalence/availability of less potent types of methamphetamine in the United States-types associated with the alternative precursor chemical P2P. Method: Using ARIMA-intervention time series analysis of monthly drug exhibits (a prevalence/availability indicator) from the System to Retrieve Information from Drug Evidence (STRIDE), we tested whether Mexico's controls, which began in 2005, were associated with growth/decline in d-methamphetamine and growth/decline in P2P-associated, less potent l-methamphetamine, racemic methamphetamine (a 50:50 ratio of d- and l-isomers), and mixed isomer methamphetamine (an unequal ratio of d- and l-isomers). Heroin, cocaine and marijuana exhibits were used for quasi-control (01/2000-04/2011). Results: Mixed-isomer exhibits constituted about 4% of the methamphetamine exhibits before Mexico's controls, then rose sharply in association with them and remained elevated, constituting about 37% of methamphetamine exhibits in 2010. d-Methamphetamine exhibits dropped sharply; l-methamphetamine and racemic methamphetamine exhibits had small rises. d-Methamphetamine exhibits partially recovered in the US West, but little recovery occurred in the US Central/South. Quasi-control series were generally unaffected. Conclusion: The US methamphetamine market changed. Widespread emergence of less potent methamphetamine occurred in conjunction with Mexico's controls. And prevalence/availability of the most potent type of the drug, d-methamphetamine, declined, a partial recovery in the West notwithstanding. Granting that lower potency drugs typically engender less dependence and attendant problems, these findings suggest that, following Mexico's controls, the potential harm of a sizeable amount of the US methamphetamine supply decreased.

AB - Background: This study examines whether Mexico's controls on ephedrine and pseudoephedrine, the two precursor chemicals that yield the most potent form of methamphetamine, d-methamphetamine, impacted the prevalence/availability of less potent types of methamphetamine in the United States-types associated with the alternative precursor chemical P2P. Method: Using ARIMA-intervention time series analysis of monthly drug exhibits (a prevalence/availability indicator) from the System to Retrieve Information from Drug Evidence (STRIDE), we tested whether Mexico's controls, which began in 2005, were associated with growth/decline in d-methamphetamine and growth/decline in P2P-associated, less potent l-methamphetamine, racemic methamphetamine (a 50:50 ratio of d- and l-isomers), and mixed isomer methamphetamine (an unequal ratio of d- and l-isomers). Heroin, cocaine and marijuana exhibits were used for quasi-control (01/2000-04/2011). Results: Mixed-isomer exhibits constituted about 4% of the methamphetamine exhibits before Mexico's controls, then rose sharply in association with them and remained elevated, constituting about 37% of methamphetamine exhibits in 2010. d-Methamphetamine exhibits dropped sharply; l-methamphetamine and racemic methamphetamine exhibits had small rises. d-Methamphetamine exhibits partially recovered in the US West, but little recovery occurred in the US Central/South. Quasi-control series were generally unaffected. Conclusion: The US methamphetamine market changed. Widespread emergence of less potent methamphetamine occurred in conjunction with Mexico's controls. And prevalence/availability of the most potent type of the drug, d-methamphetamine, declined, a partial recovery in the West notwithstanding. Granting that lower potency drugs typically engender less dependence and attendant problems, these findings suggest that, following Mexico's controls, the potential harm of a sizeable amount of the US methamphetamine supply decreased.

KW - 1-Phenyl-2-propanone (P2P)

KW - Isomer

KW - Methamphetamine

KW - Mexico

KW - Precursors

KW - Pseudoephedrine

KW - System to Retrieve Information from Drug Evidence (STRIDE)

UR - http://www.scopus.com/inward/record.url?scp=84875274659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875274659&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2012.10.001

DO - 10.1016/j.drugalcdep.2012.10.001

M3 - Article

VL - 129

SP - 125

EP - 136

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1-2

ER -